Advancements in pharmacovigilance in East Africa

Understanding the role of the Tanzania Medicines and Medical Devices Authority

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma

Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma

Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer

Primary IVIG supplementation reduces the risk of high-grade infections in patients receiving teclistamab therapy for MM

Analysis of dexamethasone-enhanced pre-medication in motixafortide-induced haematopoietic stem cell mobilisation for MM

IDH2 mutation associated with favourable outcome in older adults with newly diagnosed ALL treated with lower-intensity therapy

Overview of cancer health disparities: Current state and future directions

Bladder cancer updates from the second half of 2024

Understanding cognitive impairment for elderly patients undergoing CAR T therapy

CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC